Competitive chrodrimanin B interactions with rat brain GABAA receptors revealed by radioligand binding assays

Pestic Biochem Physiol. 2022 May:183:105074. doi: 10.1016/j.pestbp.2022.105074. Epub 2022 Mar 4.

Abstract

Meroterpenoid compounds chrodrimanins produced by Talaromyces sp. YO-2 have been shown to act as competitive antagonists of silkworm larval GABAA receptors using electrophysiology, yet no further evidence has been provided to support such an action. We have investigated the actions of chrodrimanin B on rat brain GABAA receptors by binding assays with non-competitive ligand of GABAA receptors [3H]EBOB and competitive ligands [3H]gabazine and [3H]muscimol. Chrodrimanin B did not significantly affect the binding of [3H]EBOB while reducing the binding of [3H]gabazine and [3H]muscimol to the rat membrane preparations. Chrodrimanin B increased the dissociation constant Kd of [3H]gabazine and [3H]muscimol without significantly affecting the maximum binding, pointing to competitive interactions of chrodrimanin B with rat GABAA receptors in support of our previous observation that the compound acts as a competitive antagonist on the silkworm larval GABA receptor.

Keywords: Binding assay; Chrodrimanin B; EBOB; GABA(A) receptors; Gabazine; Muscimol.

MeSH terms

  • Animals
  • Binding, Competitive
  • Bombyx* / metabolism
  • Brain / metabolism
  • Larva / metabolism
  • Muscimol / metabolism
  • Muscimol / pharmacology
  • Polyketides* / pharmacology
  • Rats
  • Receptors, GABA-A* / metabolism
  • Sesquiterpenes* / pharmacology
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Polyketides
  • Receptors, GABA-A
  • Sesquiterpenes
  • chrodrimanin B
  • Muscimol
  • gamma-Aminobutyric Acid